These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The treatment of colorectal carcinoma: standard chemotherapy and beyond. Eng C; Abbruzzese JL Clin Adv Hematol Oncol; 2004 Sep; 2(9):592-8. PubMed ID: 16163242 [TBL] [Abstract][Full Text] [Related]
27. [The new chemotherapy of colorectal cancers]. Taïeb J; Boige V; Ducreux M Presse Med; 2002 Jan; 31(3):132-8. PubMed ID: 11859739 [TBL] [Abstract][Full Text] [Related]
28. Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature. Chan DL; Pavlakis N; Shapiro J; Price TJ; Karapetis CS; Tebbutt NC; Segelov E PLoS One; 2015; 10(8):e0135599. PubMed ID: 26275292 [TBL] [Abstract][Full Text] [Related]
29. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin. Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749 [TBL] [Abstract][Full Text] [Related]
30. Targeted therapies in metastatic colorectal cancer: a systematic review and assessment of currently available data. Kirstein MM; Lange A; Prenzler A; Manns MP; Kubicka S; Vogel A Oncologist; 2014 Nov; 19(11):1156-68. PubMed ID: 25326159 [TBL] [Abstract][Full Text] [Related]
31. Current therapies for advanced colorectal cancer. Aggarwal S; Chu E Oncology (Williston Park); 2005 Apr; 19(5):589-95. PubMed ID: 15945340 [TBL] [Abstract][Full Text] [Related]
32. Cetuximab in colon cancer. Giuliani F; Colucci G Int J Biol Markers; 2007; 22(1 Suppl 4):S62-70. PubMed ID: 17520583 [TBL] [Abstract][Full Text] [Related]
33. Bevacizumab plus irinotecan-based regimens in the treatment of metastatic colorectal cancer. Heinemann V; Hoff PM Oncology; 2010; 79(1-2):118-28. PubMed ID: 21088438 [TBL] [Abstract][Full Text] [Related]
34. Adding a humanized antibody to vascular endothelial growth factor (Bevacizumab, Avastin) to chemotherapy improves survival in metastatic colorectal cancer. Clin Colorectal Cancer; 2003 Aug; 3(2):85-8. PubMed ID: 12952562 [No Abstract] [Full Text] [Related]
35. [The development of the first line treatment of metastatic colorectal cancer (mCRC)]. Landherr L; Nagykálnai T Magy Onkol; 2009 Sep; 53(3):237-46. PubMed ID: 19793687 [TBL] [Abstract][Full Text] [Related]
36. New developments in systemic chemotherapy in advanced colorectal cancer. Cats A Scand J Gastroenterol Suppl; 2003; (239):78-86. PubMed ID: 14743888 [TBL] [Abstract][Full Text] [Related]
37. [Palliative chemotherapy and radiotherapy for metastatic colorectal cancer]. Sørbye H; Braendengen M; Balteskard L Tidsskr Nor Laegeforen; 2008 Jan; 128(2):194-7. PubMed ID: 18202732 [TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor receptor monoclonal antibodies for the treatment of metastatic colorectal cancer. Jean GW; Shah SR Pharmacotherapy; 2008 Jun; 28(6):742-54. PubMed ID: 18503402 [TBL] [Abstract][Full Text] [Related]
39. [Advances in the treatment of metastatic colorectal cancer with bevacizumab]. Longo F; Mansueto G Tumori; 2006; 92(5):suppl 1-12. PubMed ID: 17168449 [No Abstract] [Full Text] [Related]
40. The role of new agents in the treatment of colorectal cancer. Folprecht G; Köhne CH Oncology; 2004; 66(1):1-17. PubMed ID: 15031593 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]